Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
07/2007
07/05/2007WO2007074213A1 Macrocyclic oligonucleotide labeling reactants and conjugates derived thereof
07/05/2007WO2007073792A1 Process for preparing 4,4- diphenylcyclohexanol
07/05/2007WO2007056417A3 Synthesis of alendronate sodium trihydrate
07/05/2007US20070155975 Cross-metathesis reaction of functionalized and substituted olefins using group 8 transition metal carbene complexes as metathesis catalysts
07/05/2007US20070155974 Transition metal catalysts
07/05/2007US20070155971 Chiral diphosphorus compounds and their transition metal complexes
07/05/2007US20070155970 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives
07/05/2007US20070155919 Organometallic transition metal compound, biscyclopentadienyl ligand system, catalyst system and preparation of polyolefins
07/05/2007US20070155875 butyl-(5-ethyl-2-butyl-1,3,2,-dioxaphosphorinan-5-yl)methyl butyl ester (P-oxide phosphonate), resorcinol bis(2,6-dimethylphenyl)phosphate;acrylonitrile-butadiene-styrene as rubber modified styrene; improved physical and mechanical properties; good impact strength, flame retardancy, heat resistance
07/05/2007US20070155839 4-[(4-Hydroxyphenyl)(3,3,5,5-tetramethylcyclohexylidene) methyl]benzoic acid; selective estrogen receptor modulation; SERMS
07/05/2007US20070155801 Advanced glycation end-product intermediaries and post-amadori inhibition
07/05/2007US20070155798 Antibiotics with improved solubility, lower toxicity; potent antibacterial activity; includes torezolid phosphate
07/05/2007US20070155705 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
07/05/2007US20070155704 t-Butyl 1-[9-[1-(tert-butoxycarbonyl)cyclopropyl]-5-oxononyl]-1-cyclopropanecarboxylate; Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, impotence
07/05/2007US20070155703 Pharmaceutically active compounds and methods of use thereof
07/05/2007US20070155702 which is a hemiethanolate octahydrate of di-sodium salt, used in the treatment of human immunodeficiency virus infection and/or acquired immunodeficiency syndrome
07/05/2007US20070154898 Multiplexing methods using dark quenchers, nonfluorescing disazo dyes, functionalized for their rapid attachment to probe components; engineered to have a desired light absorption profile; facilitate interaction between quencher and fluorophore without form nucleic acid secondary structure
07/05/2007US20070154537 Lipid-derivatized bisphosphonic acid
07/05/2007CA2634113A1 Quinolin- 4 - one derivatives as modulators of abc transporters
07/05/2007CA2633929A1 Water-soluble benzoazepine compound and its pharmaceutical composition
07/04/2007EP1803727A1 Improved process for manufacture of 4-amino-hydroxybutylidene-1,1-bisphosphonic acid and its salts
07/04/2007EP1803711A1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy
07/04/2007EP1802642A2 Fluorophosphonocinnamic compounds, synthesis and uses for treating disorders caused by oxidative stress
07/04/2007EP1802641A2 Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
07/04/2007EP1802640A1 Poly(arylene ether) composition
07/04/2007EP1802630A2 Trityl derivatives for enhancing mass spectrometry
07/04/2007EP1802560A2 Halocombstatins and methods of synthesis thereof
07/04/2007CN1993372A Method for producing phosphate silanes
07/04/2007CN1993357A Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents
07/04/2007CN1993179A Monodonor phosphonite ligands
07/04/2007CN1990493A High metathesis activity ruthenium and osmium metal carbene complexes
07/04/2007CN1324037C Multimer forms of mono- and bis-acylphosphine oxides
07/04/2007CN1324036C Biester phosphate precipitation inhibitor
07/03/2007US7238841 Polymer-supported phosphorus ligands for catalysts
07/03/2007US7238812 2-(1-isopropoxycarbonyloxy-2-methylpropyl)-7,8-dimethoxy-4(5H),10 -dioxo-2H-1,2,3-triazolo(4,5-c)(1)benzazepine, for example; chemical intermediates, synthesis using relatively inexpensive reagents
07/03/2007US7238692 Stent or a drug delivery or elution device with a disposed traiazine compound such as 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4-diamine for inhibiting smooth muscle proliferation; restenosis and atherosclerosis
07/03/2007US7238679 novel family of quinazolines (and pharmaceutically acceptable derivatives thereof that have a range of useful biological and pharmacological properties
07/03/2007CA2362069C Process for producing phosphorohalidate
07/03/2007CA2252465C Urea derivatives as inhibitors of impdh enzyme
07/03/2007CA2218638C Polymerization of alpha-olefins with transition metal catalysts based on bidentate ligands containing pyridine or quinoline moiety
06/2007
06/28/2007WO2007072851A1 Process for production of water-soluble azole prodrug
06/28/2007WO2007071453A1 Organophosphoric derivatives useful as anti-parasitic agents
06/28/2007WO2007071345A1 Sulfonated phosphine ligands and process for cross-coupling aryl halides and arylsulfonates and heteroaryl halides and heteroarylsulfonates with amines, alcohols and carbon nucleophiles by using the ligands in conjunction with transition metal catalysts
06/28/2007WO2007071320A1 Zwitterionic phosphinimine catalyst
06/28/2007WO2007002912A3 Anti-proliferative compounds, compositions, and methods of use thereof
06/28/2007US20070149820 Method for generating secondary phosphines
06/28/2007US20070149796 Method for producing orthometalated and orthosubstituted aromatic compounds
06/28/2007US20070149781 Process for preparing bisphospholane ligands
06/28/2007US20070149615 Ketone compounds and compositions for cholesterol management and related uses
06/28/2007US20070149608 3-(4-Benzyloxyphenyl) propanoic acid derivatives
06/28/2007US20070149516 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide
06/28/2007US20070149486 Process for manufacture of 4-amino-hydroxybutylidene-1,1-bisphosphonic acid and its salts
06/28/2007US20070149482 Phosphonium salts and their method of preparation
06/28/2007DE102005062363A1 Übergangsmetallkatalysatoren Transition Metal Catalysts
06/28/2007DE102005060821A1 Sulfonierte Phosphanliganden und Verfahren zur Kreuzkupplung von Aryl- und Heteroarylhalogeniden und -sulfonaten mit Aminen, Alkoholen und Kohlenstoffnucleophilen durch Einsatz der Liganden in Verbindung mit Übergangsmetall-Katalysatoren Sulfonated phosphine ligands and methods for cross-coupling of aryl and heteroaryl halides and sulfonates with amines, alcohols and carbon nucleophiles by the use of the ligand in combination with transition metal catalysts
06/28/2007CA2634362A1 Organophosphoric derivatives useful as anti-parasitic agents
06/28/2007CA2634136A1 Inositolphospholipids and analogues: phosphalidylinositol products and processes
06/28/2007CA2632842A1 Process for preparation of water-soluble azole prodrugs
06/27/2007EP1801113A1 Zwitterionic phosphinimine catalyst
06/27/2007EP1800747A1 Transition metal catalysts
06/27/2007EP1800727A1 Process for the treatment of an aqueous mixture comprising a dipolar aprotic compound
06/27/2007EP1799697A1 Method for purifying chelate ligands containing phosphorus
06/27/2007EP1799696A2 Phosphoindoles as hiv inhibitors
06/27/2007EP1799695A1 New process for the preparation of alkyl phosphinic acids
06/27/2007EP1799642A1 Process and intermediates for the selective synthesis of fluvastatin
06/27/2007EP1799640A2 Indole compounds useful as serotonin selective agents
06/27/2007EP1799634A2 Diphenylethylene compounds and uses thereof
06/27/2007EP1280784B1 Biologically active 4h-benzo 1,4|oxazin-3-ones
06/27/2007CN1989455A Oxime derivatives and the use therof as latent acids
06/27/2007CN1989145A Novel fluorinated alkylfluorophosphoric acid salt of onium and transition metal complex
06/27/2007CN1989144A N-phenylphosphoric acid triamides, method for the production thereof and their use as agents for regulating or inhibiting enzymatic urea hydrolysis
06/27/2007CN1986554A Preparing process of tri (4-ethoxy phenyl) bismuth
06/27/2007CN1986553A Precursor medicine of acyclic nucleoside phosphonic acid
06/27/2007CN1986552A Process of purifying 2'-hydroxy biphenylyl-2-phosphoacid
06/27/2007CN1986551A Process of preparing phosphate ester with mixed phenol extracted from phenol-containing industrial effluent
06/26/2007US7235696 can be prepared in an efficient manner and their electronic and steric properties are variable to a wide degree starting from readily available reactants; exhibit good performance in asymmetric syntheses
06/26/2007US7235686 Process for preparing phosphoric esters
06/26/2007US7235670 Nitroaryl derivatives that are irradiated in the presence of a sensitizer to generate bases for controlling parallel combinatorial synthesis
06/26/2007US7235666 Process for the preparation of sodium fosphenytoin
06/26/2007US7235561 Compound and a composition including such a compound
06/26/2007US7235537 Antiproliferative agents; anticancer agents; antiinflammatory agents
06/26/2007US7235510 Catalysts
06/26/2007CA2230774C Manufacture of ascorbyl monophosphates
06/26/2007CA2200225C Asymmetric ligands useful for transition metal catalyzed bond forming reactions and epoxide reactions therewith
06/26/2007CA2167464C Process for preparing dimethyl vinylphosphonate from dimethyl 2-acetoxyethanephosphonate
06/21/2007WO2007069712A1 Amine compound and use thereof for medical purposes
06/21/2007WO2007069049A2 Processes for the preparation of pure zoledronic acid
06/21/2007WO2007068718A1 Polypeptide protracting tags
06/21/2007WO2007068678A1 Process for the preparation of 3-pyridyl-1-hydroxyethylidene-1,1-biphosphonic acid and hydrated forms thereof
06/21/2007WO2007068062A1 Surface active calcium phosphates
06/21/2007WO2007039635A3 Phosphoantigen salts of organic bases and methods for their crystallization
06/21/2007WO2006020263A3 Cytoxan antibodies and immunoassay
06/21/2007WO2006002348A8 Solid and crystalline ibandronic acid
06/21/2007US20070142674 Such as such as trihydrocarbylphosphine compounds and tetrahydrocarbylphosphonium compounds, by forming solvent-insoluble iodine complexes of the components, and separating the complexes; carbonylation catalyst components for acetic acid production from methanol
06/21/2007US20070142660 Salt of a sulfur-containing, phosphorus-containing compound, and methods thereof
06/21/2007US20070142659 Sulfur-containing, phosphorus-containing compound, its salt, and methods thereof
06/21/2007US20070142658 Production method for aminophosphonic acid derivatives
06/21/2007US20070142655 use of the metal complexes as catalysts for enantioselective addition reactions with prochiral organic compounds
06/21/2007US20070142653 Inositolphospholipids and Analogues: Phosphatidylinositol Products and Processes
06/21/2007US20070142642 Method for the production of compounds with quaternary sp2-hybridised nitrogen atoms